Biocryst Pharmaceuticals (BCRX) Share-based Compensation (2010 - 2026)
Biocryst Pharmaceuticals (BCRX) recorded Share-based Compensation of $14.69 million in Q2 2026, down 31.0% from $21.3 million a year earlier and down 8.3% from the prior quarter.
Powered by 
Analysis
Biocryst Pharmaceuticals (BCRX) Share-based Compensation (2010 - 2026) Analysis & Trends
On a TTM basis, Biocryst Pharmaceuticals' Share-based Compensation came in at $73.11 million as of Jun 30, 2026, down 10.0% year-over-year; for FY2025, it was $85.07 million, up 30.0% from FY2024.
- Annual Share-based Compensation has increased for five straight years, with a five-year compound annual growth rate of 41.9% (FY2020 to FY2025).
- Across earlier years, Share-based Compensation came in at $65.41 million in FY2024 (+17.6%), $55.62 million in FY2023 (+24.4%), $44.7 million in FY2022 (+29.0%) and $34.64 million in FY2021 (+134.1%).
- The Q2 2026 figure is the lowest quarterly Share-based Compensation since Q2 2024.
- On a year-over-year basis, Share-based Compensation rose in six of the last eight quarters, with growth averaging 18.9%.
- Peak year-over-year performance for Share-based Compensation in the last five years was growth of 353.5% in Q3 2021, against a decline of 31.0% in Q2 2026 at the low end.
- Per Business Quant, the preceding three quarters came in at $16.03 million (Q1 2026), $23.79 million (Q4 2025) and $18.6 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Biocryst Pharmaceuticals | 2.16 Bn | 1.08 Bn | 214.41 Mn | 14.69 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.69 Mn |
| Mar 31, 2026 | 16.03 Mn |
| Dec 31, 2025 | 23.79 Mn |
| Sep 30, 2025 | 18.60 Mn |
| Jun 30, 2025 | 21.30 Mn |
| Mar 31, 2025 | 21.37 Mn |
| Dec 31, 2024 | 21.34 Mn |
| Sep 30, 2024 | 17.25 Mn |
| Jun 30, 2024 | 13.17 Mn |
| Mar 31, 2024 | 13.65 Mn |
| Dec 31, 2023 | 16.49 Mn |
| Sep 30, 2023 | 12.28 Mn |
| Jun 30, 2023 | 12.84 Mn |
| Mar 31, 2023 | 14.01 Mn |
| Dec 31, 2022 | 15.28 Mn |
| Sep 30, 2022 | 9.95 Mn |
| Jun 30, 2022 | 9.87 Mn |
| Mar 31, 2022 | 9.60 Mn |
| Dec 31, 2021 | 8.50 Mn |
| Sep 30, 2021 | 13.03 Mn |
API Access
Biocryst Pharmaceuticals Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=BCRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "BCRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=BCRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();